Relationship between functional disability and costs one and two years post stroke
Ingrid Lekander(Stockholm IVF), Fredrik Borgström(Quantify Research (Sweden)), Mia von Euler(University Hospital of North Norway), Hélène Pessah-Rasmussen(Lund University), Mikael Lilja(Umeå University), Katharina S. Sunnerhagen(Sahlgrenska University Hospital), Carl Willers(Stockholm IVF)
Cited by 95
Related Papers
Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
|Journal of Clinical Oncology|2000|996
Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
|Journal of Clinical Oncology|2000|840
Action Plan for Stroke in Europe 2018–2030
|European Stroke Journal|2018|601